Yann Mazabraud
Corporate Officer/Principal at RHYTHM PHARMACEUTICALS, INC.
Net worth: 2 M $ as of 2024-03-30
Profile
Yann Mazabraud currently works at Rhythm Pharmaceuticals, Inc., as Executive Vice President & Head-International from 2020.
Mr. Mazabraud also formerly worked at Genzyme Corp., as General Manager-US & Head-North America from 2016 to 2017, Genzyme Therapeutics Ltd., as Head-Latin America, and Trevi Therapeutics, Inc., as Chief Commercial Officer & Head-International from 2017 to 2020.
Mr. Mazabraud received his graduate degree from Groupe de Sup de Co La Rochelle.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2024-04-14 | 34,870 ( 0.06% ) | 2 M $ | 2024-03-30 |
Yann Mazabraud active positions
Companies | Position | Start |
---|---|---|
RHYTHM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2020-10-04 |
Former positions of Yann Mazabraud
Companies | Position | End |
---|---|---|
TREVI THERAPEUTICS, INC. | Corporate Officer/Principal | 2020-10-02 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 2017-09-30 |
Genzyme Therapeutics Ltd.
Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Corporate Officer/Principal | - |
Training of Yann Mazabraud
Groupe de Sup de Co La Rochelle | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
RHYTHM PHARMACEUTICALS, INC. | Health Technology |
TREVI THERAPEUTICS, INC. | Health Technology |
Private companies | 2 |
---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Genzyme Therapeutics Ltd.
Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Yann Mazabraud